ネクセラファーマの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/10/05 | 1,364 | 1,430 | 1,364 | 1,419 | +67 | +5% | 1,196,100 |
2020/10/02 | 1,375 | 1,385 | 1,349 | 1,352 | -21 | -1.5% | 814,600 |
2020/09/30 | 1,386 | 1,423 | 1,373 | 1,373 | -8 | -0.6% | 887,900 |
2020/09/29 | 1,377 | 1,407 | 1,374 | 1,381 | +8 | +0.6% | 670,400 |
2020/09/28 | 1,376 | 1,439 | 1,352 | 1,373 | +7 | +0.5% | 3,481,300 |
2020/09/25 | 1,354 | 1,367 | 1,339 | 1,366 | +20 | +1.5% | 385,900 |
2020/09/24 | 1,366 | 1,366 | 1,337 | 1,346 | -30 | -2.2% | 714,900 |
2020/09/23 | 1,370 | 1,380 | 1,341 | 1,376 | -3 | -0.2% | 541,900 |
2020/09/18 | 1,370 | 1,385 | 1,365 | 1,379 | +15 | +1.1% | 466,600 |
2020/09/17 | 1,410 | 1,410 | 1,359 | 1,364 | -58 | -4.1% | 1,193,700 |
2020/09/16 | 1,399 | 1,423 | 1,393 | 1,422 | +20 | +1.4% | 576,800 |
2020/09/15 | 1,405 | 1,408 | 1,383 | 1,402 | +8 | +0.6% | 401,400 |
2020/09/14 | 1,388 | 1,421 | 1,382 | 1,394 | +5 | +0.4% | 620,600 |
2020/09/11 | 1,394 | 1,394 | 1,350 | 1,389 | +10 | +0.7% | 570,200 |
2020/09/10 | 1,412 | 1,416 | 1,367 | 1,379 | -15 | -1.1% | 748,400 |
2020/09/09 | 1,366 | 1,411 | 1,362 | 1,394 | ±0 | ±0% | 807,900 |
2020/09/08 | 1,347 | 1,394 | 1,335 | 1,394 | +53 | +4% | 817,200 |
2020/09/07 | 1,343 | 1,363 | 1,325 | 1,341 | +5 | +0.4% | 1,088,800 |
2020/09/04 | 1,341 | 1,366 | 1,308 | 1,336 | -31 | -2.3% | 1,472,400 |
2020/09/03 | 1,305 | 1,373 | 1,285 | 1,367 | +73 | +5.6% | 1,694,600 |
2020/09/02 | 1,315 | 1,317 | 1,281 | 1,294 | -8 | -0.6% | 978,200 |
2020/09/01 | 1,295 | 1,302 | 1,253 | 1,302 | +16 | +1.2% | 1,214,300 |
2020/08/31 | 1,275 | 1,298 | 1,268 | 1,286 | +22 | +1.7% | 979,600 |
2020/08/28 | 1,320 | 1,331 | 1,249 | 1,264 | -59 | -4.5% | 1,807,400 |
2020/08/27 | 1,380 | 1,389 | 1,323 | 1,323 | -56 | -4.1% | 1,214,900 |
2020/08/26 | 1,375 | 1,404 | 1,358 | 1,379 | -1 | -0.1% | 723,500 |
2020/08/25 | 1,370 | 1,392 | 1,360 | 1,380 | +15 | +1.1% | 1,041,500 |
2020/08/24 | 1,407 | 1,407 | 1,333 | 1,365 | -39 | -2.8% | 1,646,100 |
2020/08/21 | 1,408 | 1,431 | 1,382 | 1,404 | +10 | +0.7% | 906,500 |
2020/08/20 | 1,421 | 1,421 | 1,385 | 1,394 | -35 | -2.4% | 787,600 |
2020/08/19 | 1,429 | 1,442 | 1,419 | 1,429 | +4 | +0.3% | 629,700 |
2020/08/18 | 1,395 | 1,434 | 1,393 | 1,425 | +50 | +3.6% | 1,145,400 |
2020/08/17 | 1,379 | 1,382 | 1,352 | 1,375 | -8 | -0.6% | 787,000 |
2020/08/14 | 1,400 | 1,417 | 1,371 | 1,383 | -42 | -2.9% | 928,600 |
2020/08/13 | 1,425 | 1,446 | 1,419 | 1,425 | +11 | +0.8% | 537,000 |
2020/08/12 | 1,400 | 1,423 | 1,399 | 1,414 | +14 | +1% | 468,700 |
2020/08/11 | 1,396 | 1,412 | 1,380 | 1,400 | +23 | +1.7% | 503,000 |
2020/08/07 | 1,387 | 1,392 | 1,359 | 1,377 | -9 | -0.6% | 517,200 |
2020/08/06 | 1,402 | 1,404 | 1,376 | 1,386 | -21 | -1.5% | 589,700 |
2020/08/05 | 1,436 | 1,440 | 1,395 | 1,407 | -29 | -2% | 580,200 |
2020/08/04 | 1,400 | 1,436 | 1,400 | 1,436 | +45 | +3.2% | 703,200 |
2020/08/03 | 1,380 | 1,406 | 1,368 | 1,391 | +20 | +1.5% | 567,600 |
2020/07/31 | 1,371 | 1,422 | 1,361 | 1,371 | -5 | -0.4% | 794,800 |
2020/07/30 | 1,352 | 1,390 | 1,343 | 1,376 | +26 | +1.9% | 695,400 |
2020/07/29 | 1,404 | 1,420 | 1,345 | 1,350 | -46 | -3.3% | 1,296,400 |
2020/07/28 | 1,475 | 1,478 | 1,391 | 1,396 | -82 | -5.5% | 1,559,200 |
2020/07/27 | 1,506 | 1,521 | 1,476 | 1,478 | -47 | -3.1% | 1,008,700 |
2020/07/22 | 1,548 | 1,553 | 1,520 | 1,525 | -30 | -1.9% | 521,700 |
2020/07/21 | 1,550 | 1,587 | 1,541 | 1,555 | +26 | +1.7% | 695,900 |
2020/07/20 | 1,520 | 1,543 | 1,498 | 1,529 | +5 | +0.3% | 830,200 |
1151~
1200
件表示中 / 5112件
類似銘柄と比較する
現在ご覧いただいている「ネクセラファーマ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ネクセラファーマ | 90,000円 | +20.3% | - | 0.00% | 159.57倍 | 1.19倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
ハートシード | 366,500円 | +174.2% | - | 0.00% | - | 11.00倍 |
|
慶応大学発ベンチャー。iPS細胞を使い独自の心筋再生用心筋球で重症心不全治療を目指す |
栄研化 | 212,900円 | +4.1% | -3.1% | 2.72% | 18.54倍 | 1.62倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
JCRファーマ | 54,800円 | +14.3% | - | 3.65% | 22.26倍 | 1.42倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
あすかHD | 232,900円 | +16.9% | +33.2% | 2.36% | 12.70倍 | 1.01倍 |
|
武田と親密。婦人科領域に強い。先発品比率引き上げに注力。21年春にあすか製薬が持株会社化 |
市場注目の銘柄
チャート関連のコラム